sgo Weekly Update MultiBriefs
Contact Us
Media Kit

Browse Categories

Browse by Date

Search past issues
Search products and services

Ovarian cancer is not the most common form of cancer, but it's among the deadliest. That's because about 70 percent of cases recur. A new study by researchers at the University of Pittsburgh, UPMC Hillman Cancer Center, Magee-Womens Research...

source: Medical Xpress

National Cancer Institute Director Ned Sharpless will serve as acting Food and Drug Administration commissioner when Scott Gottlieb leaves the agency, Health and Human Services Secretary Alex Azar said. The administration is...

source: CNBC

Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals. Scientists found that PARP inhibitors...

source: Institute of Cancer Research via Medical Xpress

Researchers at UAMS are hopeful that a vaccine they're testing could become an alternative to surgery for patients with cervical precancer. A Pap smear with abnormal results is a possible sign of cervical precancer. "It's a precursor...

source: KATV-TV

Women with high-risk HPV infection are more likely to develop cardiovascular disease than those without, the results of a study published in Circulation Research suggest. Researchers looked at data from 63,411 healthy Korean...

source: The Pharmaceutical Journal

Triple-negative breast cancer patients lack three common markers — estrogen, progesterone and HER2 — making them unresponsive to targeted therapies. A team led by University of Chicago scientists may have...

source: FierceBiotech


Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to Womens Cancer News

*First Name:
*Last Name:
Street Address:
State / Province:
Zip / Postal Code:
Are you a member of SGO? Yes   No
Privacy Policy